-
FDA Approves Updated Covid-19 Vaccines to Better Protect Against Currently Circulating Variants
On August 22, 2024, the FDA authorized new Covid-19 vaccines (2024-2025) “to include a monovalent (single) component that corresponds to the Omicron variant KP.2 strain of SARS-CoV-2. The mRNA COVID-19 vaccines have been updated with this formula to more closely target currently circulating variants and provide better protection against serious consequences of COVID-19, including hospitalization…
-
CDC Covid Information
Often, I see news agency headlines claiming to have insider information about what’s going on with the Centers for Disease Control (CDC), FDA, etc. I respect the opinions of others about government agencies. On the other hand, I like to get information straight from the horse’s mouth. With that in mind, here’s what the CDC…
-
CDC ACIP Recommendations for Covid 19 Vaccine for 2024
The CDC ACIP recommended implementation of the 2024 Covid-19 vaccine and the timeline is in the implementation slide set. CDC plans to use CDC Everything messages. Insurance plans, including Medicare, will cover the cost.
-
Reminder: CDC ACIP Meeting June 26-28 on Vaccines Including Covid-19 and RSV
Just a reminder about the upcoming CDC ACIP meeting on vaccines, including RSV and Covid-19.
-
June CDC ACIP Meeting on Covid and Other Vaccines
There’s an upcoming meeting of the CDC Advisory Committee on Immunization Practices (ACIP) June 26-28, 2024. They’ll discuss the new Covid-19 vaccine and several other vaccines including RSV.
-
FDA VRBPAC Meeting: Vaccine Targeting Lineage JN.1 for Fall 2024
I didn’t get a chance to watch the June 5th FDA advisory committee meeting on the new vaccine formulation for Covid-19 for this fall. There is a nice summary on the Minnesota CIDRAP (Center for Infectious Disease Research & Policy). The committee unanimously upvoted the selection of the JN.1 lineage strain (which includes JN.1, KP.2…
-
FDA VRBPAC Meeting on Covid Vaccine for Fall of 2024
The voting question for today’s FDA VRBPAC Meeting on the Covid Vaccine strain for this fall is: “For the 2024-2025 Formula of COVID-19 vaccines in the U.S., does thecommittee recommend a monovalent JN.1-lineage vaccine composition?Please vote “Yes” or “No” or “Abstain.” The FDA Selection of the 2024-2025 Formula for COVID-19 vaccines briefing document has a…
-
Reminder: FDA VRBPAC Meeting June 5, 2024 on Covid Vaccines for Fall 2024
There will be an FDA VRBPAC meeting on June 5, 2024, 8:30 a.m.-4:30 p.m. ET to discuss Covid vaccines for this fall.
-
FDA VRBPAC Meeting on Covid Vaccines Postponed
The May FDA VRBPAC meeting on Covid vaccines, originally scheduled for this month has been rescheduled to June 5, 2024, 8:30 AM-4:30 PM EST.
-
Reminder: FDA Advisory Committee to Meet in May 2024 to Discuss Updating Covid-19 Vaccine:
Just a reminder: the FDA Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet on May 16, 2024 to make recommendations on Covid-19 strain selections for the fall vaccine of 2024-2025.
